0.03
0.00%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Therma Bright
Its shares trade on TSX Venture under the ticker THRM.V. It has been listed since 11 July 2001. In the fiscal year to 31 July 2025, it reported revenue of C$80,269 and a net loss of C$4.3m. At that date it held total assets of C$248,695 and shareholders' equity of −C$1.6m.
Therma Bright, Inc. develops and markets skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The company focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. The company is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 11 Jul 2001
- Website
- thermabright.com ↗
Leadership
Pay as last reported
- Mr. Rob FiaPresident, Chief Executive Officer, Director, since 2009C$732,500
- Mr. Eric MyungChief Financial Officer
- Mr. Alex SaringerDirector
- Mr. Joseph HengIndependent Director$20,000
- Mr. Tim PetersonIndependent Director$20,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- The company develops proprietary healthcare devices for consumers and institutions.
- It offers a diverse product line including diagnostic tests and therapy devices.
- The Venowave is a compact, battery-operated medical compression pump.
Weaknesses
- The source description is explicitly treated as untrusted facts.
- Specific financial metrics and current revenue figures are not provided.
- Market share data and competitive positioning details are absent.
Opportunities
- The company can expand its medical device portfolio in the health care sector.
- It may leverage its manufacturing capabilities for new therapeutic solutions.
- Growth is possible in the institutional marketplace for medical devices.
Threats
- Reliance on untrusted source data creates significant information risk.
- Regulatory changes in the health care industry could impact operations.
- Market competition for skin care and circulation therapy devices is unknown.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.